Innovations In Pharmacoepidemiology
Innovations in pharmacoepidemiology are novel theories, apparatuses or procedures. Innovations are the implementation of better solutions that already exist which satisfy new needs, inarticulated needs or market requirements. It is capable of making goods, processes, services , technology, or innovative innovations more productive and readily accessible to consumers, governments , and society. Innovations are a innovative and original idea, as an essential new product that "breaks through" the market or culture. Answering the demanding questions asked of pharmacotherapy in the 21st century will require more reliance on the disciplines of pharmacoepidemiology and pharmacoeconomics. Pharmacoepidemiology can help assess patterns and appropriateness of drug utilisation, provide explanations for poor compliance, quantify the frequency and severity of side effects, and aid in the design and evaluation of interventions to improve drug use and outcomes. Pharmacoeconomics can help determine whether a new costlier product offers sufficient clinical advantage over its predecessors to justify the increased cost. Taken together, pharmacoepidemiology and pharmacoeconomics represent the next logical step in the
evolution of medication assessment; their judicious deployment can help ensure both access to new medicines and innovation.
High Impact List of Articles
-
Coronary artery percutaneous revascularization can be my best way for cardioversion: A case report
Walid Hassan, Safia Inam-ur-Rahim, Mariam Hassan, Alaa Al Nazzal, Amr W Aljareh, Hassan Mohammad Belat and Halah Zein Elabidin
Case Report: Interventional Cardiology
-
Coronary artery percutaneous revascularization can be my best way for cardioversion: A case report
Walid Hassan, Safia Inam-ur-Rahim, Mariam Hassan, Alaa Al Nazzal, Amr W Aljareh, Hassan Mohammad Belat and Halah Zein Elabidin
Case Report: Interventional Cardiology
-
Bioequivalence evaluation of pioglitazone orally disintegrating tablet formulation
Shinzo Hiroi, Kumi Matsuno, Masashi Hirayama, Takaki Hayakawa,Norihito Yoshioka & Koji Kawakami
Special Issue Article: Diabetes Management
-
Bioequivalence evaluation of pioglitazone orally disintegrating tablet formulation
Shinzo Hiroi, Kumi Matsuno, Masashi Hirayama, Takaki Hayakawa,Norihito Yoshioka & Koji Kawakami
Special Issue Article: Diabetes Management
-
Thrombolytic therapy for stroke
Jonathan Birns and Lalit Kalra
Review Article: Clinical Practice
-
Thrombolytic therapy for stroke
Jonathan Birns and Lalit Kalra
Review Article: Clinical Practice
-
Glossary: Volume 5 Issue 1
Appendices: Clinical Practice
-
Glossary: Volume 5 Issue 1
Appendices: Clinical Practice
-
Durability of therapeutic response in rheumatoid arthritis: clinical trail experience with abatacept
William Shergy
Drug Evaluation: International Journal of Clinical Rheumatology
-
Durability of therapeutic response in rheumatoid arthritis: clinical trail experience with abatacept
William Shergy
Drug Evaluation: International Journal of Clinical Rheumatology
Relevant Topics in Clinical